Home > Income Statement > BLISS GVS PHARMA

BLISS GVS PHARMA
Revenue

    Back to Income Statement
BLISS GVS PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹810 Cr₹770 Cr₹752 Cr₹747 Cr₹577 Cr

What is the latest Revenue of BLISS GVS PHARMA ?

The latest Revenue ratio of BLISS GVS PHARMA is ₹810 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹810 Cr
Mar2025₹770 Cr
Mar2024₹752 Cr
Mar2023₹747 Cr
Mar2022₹577 Cr

How is Revenue of BLISS GVS PHARMA Trending?

Years Revenue % Change
Mar2026 ₹810 Cr
5.13
Mar2025 ₹770 Cr
2.48
Mar2024 ₹752 Cr
0.55
Mar2023 ₹747 Cr
29.50
Mar2022 ₹577 Cr -

Compare Revenue of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹6,851.6 Cr -2.4% -11.1% 343% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,539.0 Cr -1.4% -6.6% 7.3% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 1.2% -2.6% 60% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,251.0 Cr -2% -6.1% 33% Stock Analytics
CIPLA ₹105,290.0 Cr -2.3% -5.8% -13.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,752.6 Cr -1.1% 3.8% -5.5% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

-2.4%

-11.1%

343%

SENSEX

0.8%

-4.8%

-10.5%


You may also like the below Video Courses